Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Health advocacy organizations and the pharmaceutical industry: an analysis of disclosure practices.

Rothman SM, Raveis VH, Friedman A, Rothman DJ.

Am J Public Health. 2011 Apr;101(4):602-9. doi: 10.2105/AJPH.2010.300027. Epub 2011 Jan 13.

2.

Independent drug review group in Canada is squeezed out.

Lenzer J.

BMJ. 2010 Dec 6;341:c7009. doi: 10.1136/bmj.c7009. No abstract available.

PMID:
21135014
3.

Drug firm's legal action against government advisers is described as "intimidation".

Moynihan R.

BMJ. 2010 Nov 17;341:c6527. doi: 10.1136/bmj.c6527. No abstract available.

PMID:
21084371
4.

The governance of standard-setting to improve health.

Fox DM.

Prev Chronic Dis. 2010 Nov;7(6):A123. Epub 2010 Oct 15.

5.

The case for a national patient library.

Lerner JC, Fox DM, Ruzek SB, Shearer GE.

Health Aff (Millwood). 2010 Oct;29(10):1914-9. doi: 10.1377/hlthaff.2010.0631.

PMID:
20921495
6.

An evaluation of recent federal spending on comparative effectiveness research: priorities, gaps, and next steps.

Benner JS, Morrison MR, Karnes EK, Kocot SL, McClellan M.

Health Aff (Millwood). 2010 Oct;29(10):1768-76. doi: 10.1377/hlthaff.2010.0687.

PMID:
20921474
7.

The political fight over comparative effectiveness research.

Iglehart JK.

Health Aff (Millwood). 2010 Oct;29(10):1757-60. doi: 10.1377/hlthaff.2010.0901. No abstract available.

PMID:
20921472
8.

Seventy-five trials and eleven systematic reviews a day: how will we ever keep up?

Bastian H, Glasziou P, Chalmers I.

PLoS Med. 2010 Sep 21;7(9):e1000326. doi: 10.1371/journal.pmed.1000326.

9.

Realizing and allocating savings from improving health care quality and efficiency.

Fox DM.

Prev Chronic Dis. 2010 Sep;7(5):A99. Epub 2010 Aug 15.

10.
11.

The origins, evolution, and future of The Cochrane Database of Systematic Reviews.

Starr M, Chalmers I, Clarke M, Oxman AD.

Int J Technol Assess Health Care. 2009 Jul;25 Suppl 1:182-95. doi: 10.1017/S026646230909062X. Epub 2009 Jun 18.

PMID:
19534840
12.

Comparative effectiveness research and evidence-based health policy: experience from four countries.

Chalkidou K, Tunis S, Lopert R, Rochaix L, Sawicki PT, Nasser M, Xerri B.

Milbank Q. 2009 Jun;87(2):339-67. doi: 10.1111/j.1468-0009.2009.00560.x.

13.

Identifying existing health care services that do not provide value for money.

Elshaug AG, Moss JR, Littlejohns P, Karnon J, Merlin TL, Hiller JE.

Med J Aust. 2009 Mar 2;190(5):269-73.

PMID:
19296794
14.

De testimonio: on the evidence for decisions about the use of therapeutic interventions.

Rawlins M.

Lancet. 2008 Dec 20;372(9656):2152-61. doi: 10.1016/S0140-6736(08)61930-3. No abstract available.

PMID:
19101391
15.

Saying no isn't NICE - the travails of Britain's National Institute for Health and Clinical Excellence.

Steinbrook R.

N Engl J Med. 2008 Nov 6;359(19):1977-81. doi: 10.1056/NEJMp0806862. No abstract available.

16.

Progress in evidence-based medicine.

Montori VM, Guyatt GH.

JAMA. 2008 Oct 15;300(15):1814-6. doi: 10.1001/jama.300.15.1814. No abstract available.

PMID:
18854545
17.

"Developing good taste in evidence": facilitators of and hindrances to evidence-informed health policymaking in state government.

Jewell CJ, Bero LA.

Milbank Q. 2008 Jun;86(2):177-208. doi: 10.1111/j.1468-0009.2008.00519.x.

18.

Epidemiology and reporting characteristics of systematic reviews.

Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG.

PLoS Med. 2007 Mar 27;4(3):e78.

19.

Health is global: proposals for a UK Government-wide strategy.

Donaldson L, Banatvala N.

Lancet. 2007 Mar 10;369(9564):857-61.

PMID:
17350456
20.

Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review.

Jørgensen AW, Hilden J, Gøtzsche PC.

BMJ. 2006 Oct 14;333(7572):782. Epub 2006 Oct 6. Review.

Supplemental Content

Support Center